Teladoc Health Inc.

40.32+2.33+6.13%Vol 4.55M1Y Perf -73.85%
Aug 12th, 2022 16:00 DELAYED
BID40.20 ASK40.50
Open39.00 Previous Close37.99
Pre-Market- After-Market40.33
 - -  0.01 0.02%
Target Price
53.50 
Analyst Rating
Hold 2.59
Potential %
32.69 
Finscreener Ranking
★★★★     54.22
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     54.92
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     53.43
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
10.00 
Earnings Rating
Strong Sell
Market Cap6.52B 
Earnings Date
27th Jul 2022
Alpha0.01 Standard Deviation0.15
Beta0.79 

Today's Price Range

38.3540.65

52W Range

27.38156.82

5 Year PE Ratio Range

-58.50-22.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
7.58%
1 Month
0.55%
3 Months
20.04%
6 Months
-44.64%
1 Year
-73.85%
3 Years
-38.83%
5 Years
32.85%
10 Years
-

TickerPriceChg.Chg.%
TDOC40.322.33006.13
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
68.10
-441.90
-431.20
-30.50
-14.77
RevenueValueIndustryS&P 500US Markets
2.23B
13.82
63.03
66.09
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.71-0.4438.03
Q01 2022-0.55-0.4714.55
Q04 2021-0.59-0.0788.14
Q03 2021-0.70-0.5324.29
Q02 2021-0.59-0.86-45.76
Q01 2021-0.570.13122.81
Q04 2020-0.25-0.27-8.00
Q03 2020-0.33-0.1360.61
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.70-55.56Negative
9/2022 QR-0.61-84.85Negative
12/2022 FY-2.05-32.26Negative
12/2023 FY-1.64-49.09Negative
Next Report Date-
Estimated EPS Next Report-0.70
Estimates Count8
EPS Growth Next 5 Years %27.30
Volume Overview
Volume4.55M
Shares Outstanding161.66K
Shares Float141.31M
Trades Count44.38K
Dollar Volume181.02M
Avg. Volume5.53M
Avg. Weekly Volume5.11M
Avg. Monthly Volume5.73M
Avg. Quarterly Volume5.73M

Teladoc Health Inc. (NYSE: TDOC) stock closed at 40.32 per share at the end of the most recent trading day (a 6.13% change compared to the prior day closing price) with a volume of 4.55M shares and market capitalization of 6.52B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 3276 people. Teladoc Health Inc. CEO is Jason N. Gorevic.

The one-year performance of Teladoc Health Inc. stock is -73.85%, while year-to-date (YTD) performance is -56.09%. TDOC stock has a five-year performance of 32.85%. Its 52-week range is between 27.38 and 156.82, which gives TDOC stock a 52-week price range ratio of 10.00%

Teladoc Health Inc. currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 1.01, a price-to-sale (PS) ratio of 2.75, a price to cashflow ratio of 27.60, a PEG ratio of 2.32, a ROA of -83.42%, a ROC of -78.82% and a ROE of -97.62%. The company’s profit margin is -14.77%, its EBITDA margin is -431.20%, and its revenue ttm is $2.23 Billion , which makes it $13.82 revenue per share.

Of the last four earnings reports from Teladoc Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.70 for the next earnings report. Teladoc Health Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Teladoc Health Inc. is Hold (2.59), with a target price of $53.5, which is +32.69% compared to the current price. The earnings rating for Teladoc Health Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Teladoc Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Teladoc Health Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 25.92, ATR14 : 3.26, CCI20 : 21.62, Chaikin Money Flow : 0.25, MACD : -0.06, Money Flow Index : 55.15, ROC : -6.75, RSI : 43.24, STOCH (14,3) : 71.76, STOCH RSI : 1.00, UO : 46.26, Williams %R : -28.24), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Teladoc Health Inc. in the last 12-months were: Adam C. Vandervoort (Option Excercise at a value of $0), Adam C. Vandervoort (Sold 12 042 shares of value $1 381 642 ), Andrew Turitz (Option Excercise at a value of $0), Andrew Turitz (Sold 1 334 shares of value $89 027 ), Arnnon Geshuri (Sold 26 430 shares of value $2 603 695 ), Catherine A. Jacobson (Option Excercise at a value of $0), Catherine Jacobson (Option Excercise at a value of $0), Christopher Bischoff (Option Excercise at a value of $0), Claus Torp Jensen (Option Excercise at a value of $0), Claus Torp Jensen (Sold 2 051 shares of value $77 620 ), Daniel Trencher (Option Excercise at a value of $223 000), Daniel Trencher (Sold 15 439 shares of value $1 489 482 ), David B. Snow (Option Excercise at a value of $0), Jason N. Gorevic (Option Excercise at a value of $0), Jason N. Gorevic (Sold 10 000 shares of value $1 508 389 ), Karen L. Daniel (Option Excercise at a value of $0), Karen L. Daniel (Sold 519 shares of value $25 355 ), Mala Murthy (Option Excercise at a value of $0), Mala Murthy (Sold 10 770 shares of value $623 037 ), Mark Douglas Smith (Option Excercise at a value of $0), Richard J. Napolitano (Option Excercise at a value of $0), Richard J. Napolitano (Sold 824 shares of value $64 813 ), Sandra L. Fenwick (Option Excercise at a value of $0), Sandra L. Fenwick (Sold 3 587 shares of value $502 180 ), Stephany Verstraete (Option Excercise at a value of $38 550), Stephany Verstraete (Sold 4 774 shares of value $406 115 ), Thomas G. McKinley (Option Excercise at a value of $0), William H. Frist (Option Excercise at a value of $45 075)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (18.18 %)
5 (26.32 %)
5 (25.00 %)
Moderate Buy
1 (4.55 %)
1 (5.26 %)
1 (5.00 %)
Hold
17 (77.27 %)
13 (68.42 %)
14 (70.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.59
Moderate Buy
2.42
Moderate Buy
2.45

Teladoc Health Inc.

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the Internet, video, and phone. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated on a subscription basis (per member per month); the balance comes from visit fees. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; most recently, the company has also started to market directly to consumers while expanding its service portfolio. The cornerstone of Teladoc's business is to provide healthcare access to members in real time to avoid excessive health plan costs.

CEO: Jason N. Gorevic

Telephone: +1 203 635-2002

Address: 2 Manhattanville Road, Purchase 10577, NY, US

Number of employees: 3 276

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%37%

Bearish Bullish

54%46%

Bearish Bullish

58%42%

TipRanks News for TDOC

Wed, 03 Aug 2022 01:49 GMT Teladoc Stock: Unhealthy Net Loss Means More Downside is Probable

- TipRanks. All rights reserved.

Sun, 24 Jul 2022 09:10 GMT Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC) and Hookipa Pharma (HOOK)

- TipRanks. All rights reserved.

Mon, 23 May 2022 15:20 GMT Teladoc Health Stock: Looks Cheap but Lacks Profitability

- TipRanks. All rights reserved.

Fri, 29 Apr 2022 14:29 GMT Has Teladoc Stock Hit Bottom Looking for the Silver Lining

- TipRanks. All rights reserved.

Thu, 28 Apr 2022 17:25 GMT Teladoc Stock: Time to Reconsider

- TipRanks. All rights reserved.

Thu, 28 Apr 2022 12:45 GMT Teladoc (TDOC) was Downgraded to a Hold Rating at Leerink Partners

- TipRanks. All rights reserved.

Thu, 28 Apr 2022 04:25 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Exact Sciences (EXAS), Teladoc (TDOC) and Guardant Health (GH)

- TipRanks. All rights reserved.

Thu, 07 Apr 2022 17:51 GMT Why Teladoc is More than a Pandemic Play

- TipRanks. All rights reserved.

Mon, 28 Mar 2022 13:57 GMT Teladoc Health: 2 Reasons for Bullishness

- TipRanks. All rights reserved.

Fri, 25 Mar 2022 18:52 GMT Teladoc: Large Dip, but Company is Still Profitless

- TipRanks. All rights reserved.

Fri, 04 Mar 2022 13:20 GMT Understanding Teladocs Newly Added Risk Factors

- TipRanks. All rights reserved.

Sun, 27 Feb 2022 08:17 GMT Teladoc: Healthier than it Seems

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 15:47 GMT Teladoc Health: Are Shares Over-Diluted

- TipRanks. All rights reserved.

Thu, 27 Jan 2022 16:12 GMT Teladoc Stock: Can It Finally Rebound from Here

- TipRanks. All rights reserved.

News

Stocktwits